Skip to main content

Developing New Master Protocols with an Innovative eTMF and eISF Solution

Learn how a global leader in neurodegenerative disease research streamlines document exchange with more than 50 research sites through Florence.

Download PDF

A global leader in neurodegenerative disease research is running the first-ever platform trial in this therapeutic area by testing multiple treatments at once —reducing the cost of research by 30 percent, decreasing the trial time by 50 percent, and increasing patient participation by 50 percent.

Learn more about how this research organization is advancing cures with Florence.